Roster, C.P.; LaVigne, D.; Milanes, J.E.; Knight, E.; Anderson, H.D.; Pizarro, S.; Harding, E.M.; Morris, M.T.; Yan, V.C.; Pham, C.-D.;
et al. Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei. Pathogens 2023, 12, 1290.
https://doi.org/10.3390/pathogens12111290
AMA Style
Roster CP, LaVigne D, Milanes JE, Knight E, Anderson HD, Pizarro S, Harding EM, Morris MT, Yan VC, Pham C-D,
et al. Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei. Pathogens. 2023; 12(11):1290.
https://doi.org/10.3390/pathogens12111290
Chicago/Turabian Style
Roster, Colm P., Danielle LaVigne, Jillian E. Milanes, Emily Knight, Heidi D. Anderson, Sabrina Pizarro, Elijah M. Harding, Meredith T. Morris, Victoria C. Yan, Cong-Dat Pham,
and et al. 2023. "Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei" Pathogens 12, no. 11: 1290.
https://doi.org/10.3390/pathogens12111290
APA Style
Roster, C. P., LaVigne, D., Milanes, J. E., Knight, E., Anderson, H. D., Pizarro, S., Harding, E. M., Morris, M. T., Yan, V. C., Pham, C.-D., Muller, F., Kwain, S., Rees, K. C., Dominy, B., Whitehead, D. C., Uddin, M. N., Millward, S. W., & Morris, J. C.
(2023). Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei. Pathogens, 12(11), 1290.
https://doi.org/10.3390/pathogens12111290
